Staying alive

References

• Gray JV, Petsko GA, Johnston GC, Ringe D, Singer RA, Werner-Washburne M. “Sleeping beauty”: quiescence in Saccharomyces cerevisiae.. Microbiol Mol Biol Rev 2004; 68:187 - 206; http://dx.doi.org/10.1128/MMBR.68.2.187-206.2004; PMID: 15187181
   PubMed Web of Science ®Google Scholar
• Werner-Washburne M, Braun E, Johnston GC, Singer RA. Stationary phase in the yeast Saccharomyces cerevisiae.. Microbiol Rev 1993; 57:383 - 401; PMID: 8393130
   PubMedGoogle Scholar
• Pringle JR, Hartwell LH. The Saccharomyces cerevisiae cell cycle. In: Broach JR, Strathern J, Jones H, eds. Molecular biology of the yeast Saccharomyces cerevisiae: life cycle and inheritance. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1981: 97-142.
   Google Scholar
• Johnston GC, Pringle JR, Hartwell LH. Coordination of growth with cell division in the yeast Saccharomyces cerevisiae.. Exp Cell Res 1977; 105:79 - 98; http://dx.doi.org/10.1016/0014-4827(77)90154-9; PMID: 320023
   PubMed Web of Science ®Google Scholar
• Piñon R. Folded chromosomes in non-cycling yeast cells: evidence for a characteristic g0 form. Chromosoma 1978; 67:263 - 74; PMID: 359278
   PubMed Web of Science ®Google Scholar
• Werner-Washburne M, Braun EL, Crawford ME, Peck VM. Stationary phase in Saccharomyces cerevisiae.. Mol Microbiol 1996; 19:1159 - 66; http://dx.doi.org/10.1111/j.1365-2958.1996.tb02461.x; PMID: 8730858
   PubMed Web of Science ®Google Scholar
• Fuge EK, Braun EL, Werner-Washburne M. Protein synthesis in long-term stationary-phase cultures of Saccharomyces cerevisiae.. J Bacteriol 1994; 176:5802 - 13; PMID: 8083172
   PubMed Web of Science ®Google Scholar
• Valentin M, Yang E. Autophagy is activated, but is not required for the G0 function of BCL-2 or BCL-xL. Cell Cycle 2008; 7:2762 - 8; http://dx.doi.org/10.4161/cc.7.17.6595; PMID: 18758240
   PubMed Web of Science ®Google Scholar
• Reed SI. The role of p34 kinases in the G1 to S-phase transition. Annu Rev Cell Biol 1992; 8:529 - 61; http://dx.doi.org/10.1146/annurev.cb.08.110192.002525; PMID: 1476805
   PubMedGoogle Scholar
• Nasmyth K. Control of the yeast cell cycle by the Cdc28 protein kinase. Curr Opin Cell Biol 1993; 5:166 - 79; http://dx.doi.org/10.1016/0955-0674(93)90099-C; PMID: 8507488
   PubMed Web of Science ®Google Scholar
• Costanzo M, Nishikawa JL, Tang X, Millman JS, Schub O, Breitkreuz K, et al. CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast. Cell 2004; 117:899 - 913; http://dx.doi.org/10.1016/j.cell.2004.05.024; PMID: 15210111
   PubMed Web of Science ®Google Scholar
• Cipriano SC, Chen YQ. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells. Oncogene 1998; 17:1549 - 56; http://dx.doi.org/10.1038/sj.onc.1202069; PMID: 9794232
   PubMed Web of Science ®Google Scholar
• Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW, et al. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J Natl Cancer Inst 1999; 91:1869 - 76; http://dx.doi.org/10.1093/jnci/91.21.1869; PMID: 10547394
   PubMed Web of Science ®Google Scholar
• Frith-Terhune A, Koh KN, Jin WJ, Chung KB, Park SK, Koh GY. Programmed changes of cell cycle regulators by serum deprivation regardless of skeletal myocyte differentiation. Mol Cells 1998; 8:637 - 46; PMID: 9856354
   PubMed Web of Science ®Google Scholar
• Resnitzky D, Hengst L, Reed SI. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol 1995; 15:4347 - 52; PMID: 7623829
   PubMed Web of Science ®Google Scholar
• Coller HA, Sang L, Roberts JM. A new description of cellular quiescence. PLoS Biol 2006; 4:e83; http://dx.doi.org/10.1371/journal.pbio.0040083; PMID: 16509772
   PubMed Web of Science ®Google Scholar
• Walkley CR, Fero ML, Chien WM, Purton LE, McArthur GA. Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 2005; 7:172 - 8; http://dx.doi.org/10.1038/ncb1214; PMID: 15654333
   PubMed Web of Science ®Google Scholar
• Steinman R, Yaroslavskiy B, Goff JP, Alber SM, Watkins SC. Cdk-inhibitors and exit from quiescence in primitive haematopoietic cell subsets. Br J Haematol 2004; 124:358 - 65; http://dx.doi.org/10.1046/j.1365-2141.2003.04780.x; PMID: 14717785
   PubMed Web of Science ®Google Scholar
• Russell RC, Fang C, Guan KL. An emerging role for TOR signaling in mammalian tissue and stem cell physiology. Development 2011; 138:3343 - 56; http://dx.doi.org/10.1242/dev.058230; PMID: 21791526
   PubMed Web of Science ®Google Scholar
• Rohde JR, Cardenas ME. Nutrient signaling through TOR kinases controls gene expression and cellular differentiation in fungi. Curr Top Microbiol Immunol 2004; 279:53 - 72; http://dx.doi.org/10.1007/978-3-642-18930-2_4; PMID: 14560951
   PubMed Web of Science ®Google Scholar
• Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D, et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011; 332:1317 - 22; http://dx.doi.org/10.1126/science.1199498; PMID: 21659604
   PubMed Web of Science ®Google Scholar
• Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, Bonenfant D, et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 2002; 10:457 - 68; http://dx.doi.org/10.1016/S1097-2765(02)00636-6; PMID: 12408816
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 2009; 10:307 - 18; http://dx.doi.org/10.1038/nrm2672; PMID: 19339977
   PubMed Web of Science ®Google Scholar
• Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 1996; 15:658 - 64; PMID: 8599949
   PubMed Web of Science ®Google Scholar
• Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 2002; 16:1472 - 87; http://dx.doi.org/10.1101/gad.995802; PMID: 12080086
   PubMed Web of Science ®Google Scholar
• Duncan R, Milburn SC, Hershey JW. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J Biol Chem 1987; 262:380 - 8; PMID: 3793730
   PubMed Web of Science ®Google Scholar
• Chou MM, Blenis J. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr Opin Cell Biol 1995; 7:806 - 14; http://dx.doi.org/10.1016/0955-0674(95)80064-6; PMID: 8608011
   PubMed Web of Science ®Google Scholar
• Ruvinsky I, Meyuhas O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 2006; 31:342 - 8; http://dx.doi.org/10.1016/j.tibs.2006.04.003; PMID: 16679021
   PubMed Web of Science ®Google Scholar
• Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 2001; 20:4370 - 9; http://dx.doi.org/10.1093/emboj/20.16.4370; PMID: 11500364
   PubMed Web of Science ®Google Scholar
• Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev Cell 2006; 11:583 - 9; http://dx.doi.org/10.1016/j.devcel.2006.08.013; PMID: 16962829
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307:1098 - 101; http://dx.doi.org/10.1126/science.1106148; PMID: 15718470
   PubMed Web of Science ®Google Scholar
• Hresko RC, Mueckler M. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 2005; 280:40406 - 16; http://dx.doi.org/10.1074/jbc.M508361200; PMID: 16221682
   PubMed Web of Science ®Google Scholar
• Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6:1122 - 8; http://dx.doi.org/10.1038/ncb1183; PMID: 15467718
   PubMed Web of Science ®Google Scholar
• Oldham S, Montagne J, Radimerski T, Thomas G, Hafen E. Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev 2000; 14:2689 - 94; http://dx.doi.org/10.1101/gad.845700; PMID: 11069885
   PubMed Web of Science ®Google Scholar
• Zhang H, Stallock JP, Ng JC, Reinhard C, Neufeld TP. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev 2000; 14:2712 - 24; http://dx.doi.org/10.1101/gad.835000; PMID: 11069888
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14:1296 - 302; http://dx.doi.org/10.1016/j.cub.2004.06.054; PMID: 15268862
   PubMed Web of Science ®Google Scholar
• Patti ME, Kahn CR. The insulin receptor--a critical link in glucose homeostasis and insulin action. J Basic Clin Physiol Pharmacol 1998; 9:89 - 109; http://dx.doi.org/10.1515/JBCPP.1998.9.2-4.89; PMID: 10212828
   PubMedGoogle Scholar
• Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471 - 84; http://dx.doi.org/10.1016/j.cell.2006.01.016; PMID: 16469695
   PubMed Web of Science ®Google Scholar
• Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489 - 501; http://dx.doi.org/10.1038/nrc839; PMID: 12094235
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4:648 - 57; http://dx.doi.org/10.1038/ncb839; PMID: 12172553
   PubMed Web of Science ®Google Scholar
• Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 2002; 4:658 - 65; http://dx.doi.org/10.1038/ncb840; PMID: 12172554
   PubMed Web of Science ®Google Scholar
• Miron M, Lasko P, Sonenberg N. Signaling from Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila melanogaster.. Mol Cell Biol 2003; 23:9117 - 26; http://dx.doi.org/10.1128/MCB.23.24.9117-9126.2003; PMID: 14645523
   PubMed Web of Science ®Google Scholar
• Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 2003; 11:1457 - 66; http://dx.doi.org/10.1016/S1097-2765(03)00220-X; PMID: 12820960
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17:1829 - 34; http://dx.doi.org/10.1101/gad.1110003; PMID: 12869586
   PubMed Web of Science ®Google Scholar
• Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003; 13:1259 - 68; http://dx.doi.org/10.1016/S0960-9822(03)00506-2; PMID: 12906785
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115:577 - 90; http://dx.doi.org/10.1016/S0092-8674(03)00929-2; PMID: 14651849
   PubMed Web of Science ®Google Scholar
• Tee AR, Anjum R, Blenis J. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. J Biol Chem 2003; 278:37288 - 96; http://dx.doi.org/10.1074/jbc.M303257200; PMID: 12867426
   PubMed Web of Science ®Google Scholar
• Castro AF, Rebhun JF, Clark GJ, Quilliam LA. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 2003; 278:32493 - 6; http://dx.doi.org/10.1074/jbc.C300226200; PMID: 12842888
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 2003; 28:573 - 6; http://dx.doi.org/10.1016/j.tibs.2003.09.003; PMID: 14607085
   PubMed Web of Science ®Google Scholar
• Rameh LE, Cantley LC. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 1999; 274:8347 - 50; http://dx.doi.org/10.1074/jbc.274.13.8347; PMID: 10085060
   PubMed Web of Science ®Google Scholar
• Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999; 68:965 - 1014; http://dx.doi.org/10.1146/annurev.biochem.68.1.965; PMID: 10872470
   PubMed Web of Science ®Google Scholar
• Jaeschke A, Hartkamp J, Saitoh M, Roworth W, Nobukuni T, Hodges A, et al. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J Cell Biol 2002; 159:217 - 24; http://dx.doi.org/10.1083/jcb.jcb.200206108; PMID: 12403809
   PubMed Web of Science ®Google Scholar
• Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 2002; 4:699 - 704; http://dx.doi.org/10.1038/ncb847; PMID: 12172555
   PubMed Web of Science ®Google Scholar
• Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A 2002; 99:13571 - 6; http://dx.doi.org/10.1073/pnas.202476899; PMID: 12271141
   PubMed Web of Science ®Google Scholar
• Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 2002; 10:151 - 62; http://dx.doi.org/10.1016/S1097-2765(02)00568-3; PMID: 12150915
   PubMed Web of Science ®Google Scholar
• Franz DN. Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis. Expert Rev Anticancer Ther 2011; 11:1181 - 92; http://dx.doi.org/10.1586/era.11.93; PMID: 21916571
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 2004; 101:3329 - 35; http://dx.doi.org/10.1073/pnas.0308061100; PMID: 14985505
   PubMed Web of Science ®Google Scholar
• Lizcano JM, Göransson O, Toth R, Deak M, Morrice NA, Boudeau J, et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 2004; 23:833 - 43; http://dx.doi.org/10.1038/sj.emboj.7600110; PMID: 14976552
   PubMed Web of Science ®Google Scholar
• Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003; 13:2004 - 8; http://dx.doi.org/10.1016/j.cub.2003.10.031; PMID: 14614828
   PubMed Web of Science ®Google Scholar
• Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Mäkelä TP, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003; 2:28; http://dx.doi.org/10.1186/1475-4924-2-28; PMID: 14511394
   PubMedGoogle Scholar
• Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007; 8:774 - 85; http://dx.doi.org/10.1038/nrm2249; PMID: 17712357
   PubMed Web of Science ®Google Scholar
• Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30:214 - 26; http://dx.doi.org/10.1016/j.molcel.2008.03.003; PMID: 18439900
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6:91 - 9; http://dx.doi.org/10.1016/j.ccr.2004.06.007; PMID: 15261145
   PubMed Web of Science ®Google Scholar
• Barbet NC, Schneider U, Helliwell SB, Stansfield I, Tuite MF, Hall MN. TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell 1996; 7:25 - 42; PMID: 8741837
   PubMed Web of Science ®Google Scholar
• Sousa-Nunes R, Yee LL, Gould AP. Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila.. Nature 2011; 471:508 - 12; http://dx.doi.org/10.1038/nature09867; PMID: 21346761
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814 - 22; http://dx.doi.org/10.1038/ncb0910-814; PMID: 20811353
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. Autophagy and metabolism. Science 2010; 330:1344 - 8; http://dx.doi.org/10.1126/science.1193497; PMID: 21127245
   PubMed Web of Science ®Google Scholar
• Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 2008; 10:935 - 45; http://dx.doi.org/10.1038/ncb1753; PMID: 18604198
   PubMed Web of Science ®Google Scholar
• Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010; 141:290 - 303; http://dx.doi.org/10.1016/j.cell.2010.02.024; PMID: 20381137
   PubMed Web of Science ®Google Scholar
• Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008; 320:1496 - 501; http://dx.doi.org/10.1126/science.1157535; PMID: 18497260
   PubMed Web of Science ®Google Scholar
• Chang YY, Neufeld TP. An Atg1/Atg13 complex with multiple roles in TOR-mediated autophagy regulation. Mol Biol Cell 2009; 20:2004 - 14; http://dx.doi.org/10.1091/mbc.E08-12-1250; PMID: 19225150
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20:1992 - 2003; http://dx.doi.org/10.1091/mbc.E08-12-1249; PMID: 19225151
   PubMed Web of Science ®Google Scholar
• Kamada Y, Yoshino K, Kondo C, Kawamata T, Oshiro N, Yonezawa K, et al. Tor directly controls the Atg1 kinase complex to regulate autophagy. Mol Cell Biol 2010; 30:1049 - 58; http://dx.doi.org/10.1128/MCB.01344-09; PMID: 19995911
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20:1981 - 91; http://dx.doi.org/10.1091/mbc.E08-12-1248; PMID: 19211835
   PubMed Web of Science ®Google Scholar
• Dunn WA Jr.. Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol 1994; 4:139 - 43; http://dx.doi.org/10.1016/0962-8924(94)90069-8; PMID: 14731737
   PubMedGoogle Scholar
• Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717 - 21; http://dx.doi.org/10.1126/science.290.5497.1717; PMID: 11099404
   PubMed Web of Science ®Google Scholar
• Tsukamoto S, Kuma A, Murakami M, Kishi C, Yamamoto A, Mizushima N. Autophagy is essential for preimplantation development of mouse embryos. Science 2008; 321:117 - 20; http://dx.doi.org/10.1126/science.1154822; PMID: 18599786
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005; 169:425 - 34; http://dx.doi.org/10.1083/jcb.200412022; PMID: 15866887
   PubMed Web of Science ®Google Scholar
• Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, et al. The role of autophagy during the early neonatal starvation period. Nature 2004; 432:1032 - 6; http://dx.doi.org/10.1038/nature03029; PMID: 15525940
   PubMed Web of Science ®Google Scholar
• Sou YS, Waguri S, Iwata J, Ueno T, Fujimura T, Hara T, et al. The Atg8 conjugation system is indispensable for proper development of autophagic isolation membranes in mice. Mol Biol Cell 2008; 19:4762 - 75; http://dx.doi.org/10.1091/mbc.E08-03-0309; PMID: 18768753
   PubMed Web of Science ®Google Scholar
• Berry DL, Baehrecke EH. Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila.. Cell 2007; 131:1137 - 48; http://dx.doi.org/10.1016/j.cell.2007.10.048; PMID: 18083103
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 147:728 - 41; http://dx.doi.org/10.1016/j.cell.2011.10.026; PMID: 22078875
   PubMed Web of Science ®Google Scholar
• Navarro Llorens JM, Tormo A, Martínez-García E. Stationary phase in gram-negative bacteria. FEMS Microbiol Rev 2010; 34:476 - 95; http://dx.doi.org/10.1111/j.1574-6976.2010.00213.x; PMID: 20236330
   PubMed Web of Science ®Google Scholar
• Lacour S, Landini P. SigmaS-dependent gene expression at the onset of stationary phase in Escherichia coli: function of sigmaS-dependent genes and identification of their promoter sequences. J Bacteriol 2004; 186:7186 - 95; http://dx.doi.org/10.1128/JB.186.21.7186-7195.2004; PMID: 15489429
   PubMed Web of Science ®Google Scholar
• Weber H, Polen T, Heuveling J, Wendisch VF, Hengge R. Genome-wide analysis of the general stress response network in Escherichia coli: sigmaS-dependent genes, promoters, and sigma factor selectivity. J Bacteriol 2005; 187:1591 - 603; http://dx.doi.org/10.1128/JB.187.5.1591-1603.2005; PMID: 15716429
   PubMed Web of Science ®Google Scholar
• Hengge-Aronis R. Signal transduction and regulatory mechanisms involved in control of the sigma(S) (RpoS) subunit of RNA polymerase. [table of contents.] Microbiol Mol Biol Rev 2002; 66:373 - 95; http://dx.doi.org/10.1128/MMBR.66.3.373-395.2002; PMID: 12208995
   PubMed Web of Science ®Google Scholar
• Jenkins DE, Chaisson SA, Matin A. Starvation-induced cross protection against osmotic challenge in Escherichia coli.. J Bacteriol 1990; 172:2779 - 81; PMID: 2185233
   PubMed Web of Science ®Google Scholar
• Givskov M, Eberl L, Møller S, Poulsen LK, Molin S. Responses to nutrient starvation in Pseudomonas putida KT2442: analysis of general cross-protection, cell shape, and macromolecular content. J Bacteriol 1994; 176:7 - 14; PMID: 8282712
   PubMed Web of Science ®Google Scholar
• Zambrano MM, Siegele DA, Almirón M, Tormo A, Kolter R. Microbial competition: Escherichia coli mutants that take over stationary phase cultures. Science 1993; 259:1757 - 60; http://dx.doi.org/10.1126/science.7681219; PMID: 7681219
   PubMed Web of Science ®Google Scholar
• Reeve CA, Amy PS, Matin A. Role of protein synthesis in the survival of carbon-starved Escherichia coli K-12. J Bacteriol 1984; 160:1041 - 6; PMID: 6389505
   PubMed Web of Science ®Google Scholar
• Yoshida H, Maki Y, Kato H, Fujisawa H, Izutsu K, Wada C, et al. The ribosome modulation factor (RMF) binding site on the 100S ribosome of Escherichia coli.. J Biochem 2002; 132:983 - 9; http://dx.doi.org/10.1093/oxfordjournals.jbchem.a003313; PMID: 12473202
   PubMed Web of Science ®Google Scholar
• Brown L, Gentry D, Elliott T, Cashel M. DksA affects ppGpp induction of RpoS at a translational level. J Bacteriol 2002; 184:4455 - 65; http://dx.doi.org/10.1128/JB.184.16.4455-4465.2002; PMID: 12142416
   PubMed Web of Science ®Google Scholar
• Nyström T. Stationary-phase physiology. Annu Rev Microbiol 2004; 58:161 - 81; http://dx.doi.org/10.1146/annurev.micro.58.030603.123818; PMID: 15487934
   PubMed Web of Science ®Google Scholar
• Nyström T, Larsson C, Gustafsson L. Bacterial defense against aging: role of the Escherichia coli ArcA regulator in gene expression, readjusted energy flux and survival during stasis. EMBO J 1996; 15:3219 - 28; PMID: 8670822
   PubMed Web of Science ®Google Scholar
• Groat RG, Schultz JE, Zychlinsky E, Bockman A, Matin A. Starvation proteins in Escherichia coli: kinetics of synthesis and role in starvation survival. J Bacteriol 1986; 168:486 - 93; PMID: 3536847
   PubMed Web of Science ®Google Scholar
• Reeve CA, Bockman AT, Matin A. Role of protein degradation in the survival of carbon-starved Escherichia coli and Salmonella typhimurium.. J Bacteriol 1984; 157:758 - 63; PMID: 6365890
   PubMed Web of Science ®Google Scholar
• Weichart D, Querfurth N, Dreger M, Hengge-Aronis R. Global role for ClpP-containing proteases in stationary-phase adaptation of Escherichia coli.. J Bacteriol 2003; 185:115 - 25; http://dx.doi.org/10.1128/JB.185.1.115-125.2003; PMID: 12486047
   PubMed Web of Science ®Google Scholar
• Thevelein JM, Cauwenberg L, Colombo S, Donation M, Dumortier F, Kraakman L, et al, De Winde JH, Van Dijck P. Nutrient-induced signal transduction through the protein kinase A pathway and its role in the control of metabolism, stress resistance, and growth in yeast. Enzyme Microb Technol 2000; 26:819 - 25; http://dx.doi.org/10.1016/S0141-0229(00)00177-0; PMID: 10862891
   PubMed Web of Science ®Google Scholar
• Allen C, Büttner S, Aragon AD, Thomas JA, Meirelles O, Jaetao JE, et al. Isolation of quiescent and nonquiescent cells from yeast stationary-phase cultures. J Cell Biol 2006; 174:89 - 100; http://dx.doi.org/10.1083/jcb.200604072; PMID: 16818721
   PubMed Web of Science ®Google Scholar
• Choder M. A general topoisomerase I-dependent transcriptional repression in the stationary phase in yeast. Genes Dev 1991; 5:12A 2315 - 26; http://dx.doi.org/10.1101/gad.5.12a.2315; PMID: 1660829
   PubMed Web of Science ®Google Scholar
• Lillie SH, Pringle JR. Reserve carbohydrate metabolism in Saccharomyces cerevisiae: responses to nutrient limitation. J Bacteriol 1980; 143:1384 - 94; PMID: 6997270
   PubMed Web of Science ®Google Scholar
• Silljé HH, ter Schure EG, Rommens AJ, Huls PG, Woldringh CL, Verkleij AJ, et al. Effects of different carbon fluxes on G1 phase duration, cyclin expression, and reserve carbohydrate metabolism in Saccharomyces cerevisiae.. J Bacteriol 1997; 179:6560 - 5; PMID: 9352900
   PubMed Web of Science ®Google Scholar
• Silljé HH, Paalman JW, ter Schure EG, Olsthoorn SQ, Verkleij AJ, Boonstra J, et al. Function of trehalose and glycogen in cell cycle progression and cell viability in Saccharomyces cerevisiae.. J Bacteriol 1999; 181:396 - 400; PMID: 9882651
   PubMed Web of Science ®Google Scholar
• François J, Parrou JL. Reserve carbohydrates metabolism in the yeast Saccharomyces cerevisiae.. FEMS Microbiol Rev 2001; 25:125 - 45; http://dx.doi.org/10.1016/S0168-6445(00)00059-0; PMID: 11152943
   PubMed Web of Science ®Google Scholar
• Shi L, Sutter BM, Ye X, Tu BP. Trehalose is a key determinant of the quiescent metabolic state that fuels cell cycle progression upon return to growth. Mol Biol Cell 2010; 21:1982 - 90; http://dx.doi.org/10.1091/mbc.E10-01-0056; PMID: 20427572
   PubMed Web of Science ®Google Scholar
• Slaughter JC, Nomura T. Intracellular glycogen and trehalose contents as predictors of yeast viability. Enzyme Microb Technol 1992; 14:64 - 7; http://dx.doi.org/10.1016/0141-0229(92)90028-M
   Web of Science ®Google Scholar
• Singer MA, Lindquist S. Multiple effects of trehalose on protein folding in vitro and in vivo. Mol Cell 1998; 1:639 - 48; http://dx.doi.org/10.1016/S1097-2765(00)80064-7; PMID: 9660948
   PubMed Web of Science ®Google Scholar
• Luyckx J, Baudouin C. Trehalose: an intriguing disaccharide with potential for medical application in ophthalmology. Clin Ophthalmol 2011; 5:577 - 81; PMID: 21654884
   PubMedGoogle Scholar
• Kandror O, Bretschneider N, Kreydin E, Cavalieri D, Goldberg AL. Yeast adapt to near-freezing temperatures by STRE/Msn2,4-dependent induction of trehalose synthesis and certain molecular chaperones. Mol Cell 2004; 13:771 - 81; http://dx.doi.org/10.1016/S1097-2765(04)00148-0; PMID: 15053871
   PubMed Web of Science ®Google Scholar
• Teramoto N, Sachinvala ND, Shibata M. Trehalose and trehalose-based polymers for environmentally benign, biocompatible and bioactive materials. Molecules 2008; 13:1773 - 816; http://dx.doi.org/10.3390/molecules13081773; PMID: 18794785
   PubMed Web of Science ®Google Scholar
• Leidy C, Gousset K, Ricker J, Wolkers WF, Tsvetkova NM, Tablin F, et al. Lipid phase behavior and stabilization of domains in membranes of platelets. Cell Biochem Biophys 2004; 40:123 - 48; http://dx.doi.org/10.1385/CBB:40:2:123; PMID: 15054219
   PubMed Web of Science ®Google Scholar
• Singer MA, Lindquist S. Thermotolerance in Saccharomyces cerevisiae: the Yin and Yang of trehalose. Trends Biotechnol 1998; 16:460 - 8; http://dx.doi.org/10.1016/S0167-7799(98)01251-7; PMID: 9830154
   PubMed Web of Science ®Google Scholar
• Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991; 253:905 - 9; http://dx.doi.org/10.1126/science.1715094; PMID: 1715094
   PubMed Web of Science ®Google Scholar
• Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 1993; 73:585 - 96; http://dx.doi.org/10.1016/0092-8674(93)90144-F; PMID: 8387896
   PubMed Web of Science ®Google Scholar
• Hardwick JS, Kuruvilla FG, Tong JK, Shamji AF, Schreiber SL. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci U S A 1999; 96:14866 - 70; http://dx.doi.org/10.1073/pnas.96.26.14866; PMID: 10611304
   PubMed Web of Science ®Google Scholar
• Noda T, Ohsumi Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J Biol Chem 1998; 273:3963 - 6; http://dx.doi.org/10.1074/jbc.273.7.3963; PMID: 9461583
   PubMed Web of Science ®Google Scholar
• Rohde JR, Bastidas R, Puria R, Cardenas ME. Nutritional control via Tor signaling in Saccharomyces cerevisiae.. Curr Opin Microbiol 2008; 11:153 - 60; http://dx.doi.org/10.1016/j.mib.2008.02.013; PMID: 18396450
   PubMed Web of Science ®Google Scholar
• De Virgilio C, Loewith R. Cell growth control: little eukaryotes make big contributions. Oncogene 2006; 25:6392 - 415; http://dx.doi.org/10.1038/sj.onc.1209884; PMID: 17041625
   PubMed Web of Science ®Google Scholar
• Crespo JL, Hall MN. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.. [table of contents.] Microbiol Mol Biol Rev 2002; 66:579 - 91; http://dx.doi.org/10.1128/MMBR.66.4.579-591.2002; PMID: 12456783
   PubMed Web of Science ®Google Scholar
• Kuruvilla FG, Shamji AF, Schreiber SL. Carbon- and nitrogen-quality signaling to translation are mediated by distinct GATA-type transcription factors. Proc Natl Acad Sci U S A 2001; 98:7283 - 8; http://dx.doi.org/10.1073/pnas.121186898; PMID: 11416207
   PubMed Web of Science ®Google Scholar
• Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001; 15:807 - 26; http://dx.doi.org/10.1101/gad.887201; PMID: 11297505
   PubMed Web of Science ®Google Scholar
• Cosentino GP, Schmelzle T, Haghighat A, Helliwell SB, Hall MN, Sonenberg N. Eap1p, a novel eukaryotic translation initiation factor 4E-associated protein in Saccharomyces cerevisiae.. Mol Cell Biol 2000; 20:4604 - 13; http://dx.doi.org/10.1128/MCB.20.13.4604-4613.2000; PMID: 10848587
   PubMed Web of Science ®Google Scholar
• Berset C, Trachsel H, Altmann M. The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast Saccharomyces cerevisiae.. Proc Natl Acad Sci U S A 1998; 95:4264 - 9; http://dx.doi.org/10.1073/pnas.95.8.4264; PMID: 9539725
   PubMed Web of Science ®Google Scholar
• Powers T, Walter P. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae.. Mol Biol Cell 1999; 10:987 - 1000; PMID: 10198052
   PubMed Web of Science ®Google Scholar
• Urban J, Soulard A, Huber A, Lippman S, Mukhopadhyay D, Deloche O, et al. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae.. Mol Cell 2007; 26:663 - 74; http://dx.doi.org/10.1016/j.molcel.2007.04.020; PMID: 17560372
   PubMed Web of Science ®Google Scholar
• Jorgensen P, Rupes I, Sharom JR, Schneper L, Broach JR, Tyers M. A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev 2004; 18:2491 - 505; http://dx.doi.org/10.1101/gad.1228804; PMID: 15466158
   PubMed Web of Science ®Google Scholar
• Jorgensen P, Nishikawa JL, Breitkreutz BJ, Tyers M. Systematic identification of pathways that couple cell growth and division in yeast. Science 2002; 297:395 - 400; http://dx.doi.org/10.1126/science.1070850; PMID: 12089449
   PubMed Web of Science ®Google Scholar
• Huber A, Bodenmiller B, Uotila A, Stahl M, Wanka S, Gerrits B, et al. Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev 2009; 23:1929 - 43; http://dx.doi.org/10.1101/gad.532109; PMID: 19684113
   PubMed Web of Science ®Google Scholar
• Huber A, French SL, Tekotte H, Yerlikaya S, Stahl M, Perepelkina MP, et al. Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L. EMBO J 2011; 30:3052 - 64; http://dx.doi.org/10.1038/emboj.2011.221; PMID: 21730963
   PubMed Web of Science ®Google Scholar
• Kim JE, Chen J. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc Natl Acad Sci U S A 2000; 97:14340 - 5; http://dx.doi.org/10.1073/pnas.011511898; PMID: 11114166
   PubMed Web of Science ®Google Scholar
• Di Como CJ, Arndt KT. Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev 1996; 10:1904 - 16; http://dx.doi.org/10.1101/gad.10.15.1904; PMID: 8756348
   PubMed Web of Science ®Google Scholar
• Jiang Y, Broach JR. Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J 1999; 18:2782 - 92; http://dx.doi.org/10.1093/emboj/18.10.2782; PMID: 10329624
   PubMed Web of Science ®Google Scholar
• Düvel K, Broach JR. The role of phosphatases in TOR signaling in yeast. Curr Top Microbiol Immunol 2004; 279:19 - 38; http://dx.doi.org/10.1007/978-3-642-18930-2_2; PMID: 14560949
   PubMed Web of Science ®Google Scholar
• Arndt KT, Styles CA, Fink GR. A suppressor of a HIS4 transcriptional defect encodes a protein with homology to the catalytic subunit of protein phosphatases. Cell 1989; 56:527 - 37; http://dx.doi.org/10.1016/0092-8674(89)90576-X; PMID: 2537149
   PubMed Web of Science ®Google Scholar
• Sutton A, Immanuel D, Arndt KT. The SIT4 protein phosphatase functions in late G1 for progression into S phase. Mol Cell Biol 1991; 11:2133 - 48; PMID: 1848673
   PubMed Web of Science ®Google Scholar
• Beck T, Hall MN. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature 1999; 402:689 - 92; http://dx.doi.org/10.1038/45287; PMID: 10604478
   PubMed Web of Science ®Google Scholar
• Schmidt A, Beck T, Koller A, Kunz J, Hall MN. The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease. EMBO J 1998; 17:6924 - 31; http://dx.doi.org/10.1093/emboj/17.23.6924; PMID: 9843498
   PubMed Web of Science ®Google Scholar
• Jacinto E, Guo B, Arndt KT, Schmelzle T, Hall MN. TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol Cell 2001; 8:1017 - 26; http://dx.doi.org/10.1016/S1097-2765(01)00386-0; PMID: 11741537
   PubMed Web of Science ®Google Scholar
• Roosen J, Engelen K, Marchal K, Mathys J, Griffioen G, Cameroni E, et al. PKA and Sch9 control a molecular switch important for the proper adaptation to nutrient availability. Mol Microbiol 2005; 55:862 - 80; http://dx.doi.org/10.1111/j.1365-2958.2004.04429.x; PMID: 15661010
   PubMed Web of Science ®Google Scholar
• Cherkasova VA, Hinnebusch AG. Translational control by TOR and TAP42 through dephosphorylation of eIF2alpha kinase GCN2. Genes Dev 2003; 17:859 - 72; http://dx.doi.org/10.1101/gad.1069003; PMID: 12654728
   PubMed Web of Science ®Google Scholar
• Cameroni E, Hulo N, Roosen J, Winderickx J, De Virgilio C. The novel yeast PAS kinase Rim 15 orchestrates G0-associated antioxidant defense mechanisms. Cell Cycle 2004; 3:462 - 8; http://dx.doi.org/10.4161/cc.3.4.791; PMID: 15300954
   PubMed Web of Science ®Google Scholar
• Fabrizio P, Pletcher SD, Minois N, Vaupel JW, Longo VD. Chronological aging-independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae.. FEBS Lett 2004; 557:136 - 42; http://dx.doi.org/10.1016/S0014-5793(03)01462-5; PMID: 14741356
   PubMed Web of Science ®Google Scholar
• Longo VD, Gralla EB, Valentine JS. Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae. Mitochondrial production of toxic oxygen species in vivo. J Biol Chem 1996; 271:12275 - 80; PMID: 8647826
   PubMed Web of Science ®Google Scholar
• Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae.. FEBS Lett 1993; 333:169 - 74; http://dx.doi.org/10.1016/0014-5793(93)80398-E; PMID: 8224160
   PubMed Web of Science ®Google Scholar
• Onodera J, Ohsumi Y. Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J Biol Chem 2005; 280:31582 - 6; http://dx.doi.org/10.1074/jbc.M506736200; PMID: 16027116
   PubMed Web of Science ®Google Scholar
• Suzuki SW, Onodera J, Ohsumi Y. Starvation induced cell death in autophagy-defective yeast mutants is caused by mitochondria dysfunction. PLoS One 2011; 6:e17412; http://dx.doi.org/10.1371/journal.pone.0017412; PMID: 21364763
   PubMed Web of Science ®Google Scholar
• Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 2000; 150:1507 - 13; http://dx.doi.org/10.1083/jcb.150.6.1507; PMID: 10995454
   PubMed Web of Science ®Google Scholar
• Kamada Y, Sekito T, Ohsumi Y. Autophagy in yeast: a TOR-mediated response to nutrient starvation. Curr Top Microbiol Immunol 2004; 279:73 - 84; http://dx.doi.org/10.1007/978-3-642-18930-2_5; PMID: 14560952
   PubMed Web of Science ®Google Scholar
• Prasad KV, Cai YC, Raab M, Duckworth B, Cantley L, Shoelson SE, et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci U S A 1994; 91:2834 - 8; http://dx.doi.org/10.1073/pnas.91.7.2834; PMID: 8146197
   PubMed Web of Science ®Google Scholar
• Pagès F, Ragueneau M, Rottapel R, Truneh A, Nunes J, Imbert J, et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 1994; 369:327 - 9; http://dx.doi.org/10.1038/369327a0; PMID: 8183372
   PubMed Web of Science ®Google Scholar
• August A, Dupont B. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int Immunol 1994; 6:769 - 74; http://dx.doi.org/10.1093/intimm/6.5.769; PMID: 8080844
   PubMed Web of Science ®Google Scholar
• Krauss S, Brand MD, Buttgereit F. Signaling takes a breath--new quantitative perspectives on bioenergetics and signal transduction. Immunity 2001; 15:497 - 502; http://dx.doi.org/10.1016/S1074-7613(01)00205-9; PMID: 11672532
   PubMed Web of Science ®Google Scholar
• Edinger AL, Thompson CB. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 2002; 13:2276 - 88; http://dx.doi.org/10.1091/mbc.01-12-0584; PMID: 12134068
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Vander Heiden MG, Harris MH, Frauwirth KA, Thompson CB. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol Cell 2000; 6:683 - 92; http://dx.doi.org/10.1016/S1097-2765(00)00066-6; PMID: 11030347
   PubMed Web of Science ®Google Scholar
• Kan O, Baldwin SA, Whetton AD. Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line. J Exp Med 1994; 180:917 - 23; http://dx.doi.org/10.1084/jem.180.3.917; PMID: 8064240
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 2003; 23:7315 - 28; http://dx.doi.org/10.1128/MCB.23.20.7315-7328.2003; PMID: 14517300
   PubMed Web of Science ®Google Scholar
• Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005; 5:844 - 52; http://dx.doi.org/10.1038/nri1710; PMID: 16239903
   PubMed Web of Science ®Google Scholar
• Bental M, Deutsch C. Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med 1993; 29:317 - 26; http://dx.doi.org/10.1002/mrm.1910290307; PMID: 8450740
   PubMed Web of Science ®Google Scholar
• Brand K. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem J 1985; 228:353 - 61; PMID: 2861809
   PubMed Web of Science ®Google Scholar
• Roos D, Loos JA. Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin. Biochim Biophys Acta 1970; 222:565 - 82; http://dx.doi.org/10.1016/0304-4165(70)90182-0; PMID: 5496487
   PubMed Web of Science ®Google Scholar
• Hedeskov CJ. Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes. Biochem J 1968; 110:373 - 80; PMID: 5726214
   PubMed Web of Science ®Google Scholar
• Culvenor JG, Weidemann MJ. Phytohaemagglutinin stimulation of rat thymus lymphocytes glycolysis. Biochim Biophys Acta 1976; 437:354 - 63; http://dx.doi.org/10.1016/0304-4165(76)90005-2; PMID: 1085166
   PubMed Web of Science ®Google Scholar
• Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity 2007; 27:173 - 8; http://dx.doi.org/10.1016/j.immuni.2007.07.008; PMID: 17723208
   PubMed Web of Science ®Google Scholar
• Bauer DE, Harris MH, Plas DR, Lum JJ, Hammerman PS, Rathmell JC, et al. Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB J 2004; 18:1303 - 5; PMID: 15180958
   PubMed Web of Science ®Google Scholar
• Kim JW, Dang CV. Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 2006; 66:8927 - 30; http://dx.doi.org/10.1158/0008-5472.CAN-06-1501; PMID: 16982728
   PubMed Web of Science ®Google Scholar
• Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol 2006; 18:598 - 608; http://dx.doi.org/10.1016/j.ceb.2006.10.005; PMID: 17046224
   PubMed Web of Science ®Google Scholar
• Watson RT, Kanzaki M, Pessin JE. Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 2004; 25:177 - 204; http://dx.doi.org/10.1210/er.2003-0011; PMID: 15082519
   PubMed Web of Science ®Google Scholar
• Dugani CB, Klip A. Glucose transporter 4: cycling, compartments and controversies. EMBO Rep 2005; 6:1137 - 42; http://dx.doi.org/10.1038/sj.embor.7400584; PMID: 16319959
   PubMed Web of Science ®Google Scholar
• Koistinen HA, Zierath JR. Regulation of glucose transport in human skeletal muscle. Ann Med 2002; 34:410 - 8; http://dx.doi.org/10.1080/078538902321012351; PMID: 12523496
   PubMed Web of Science ®Google Scholar
• Bentley J, Itchayanan D, Barnes K, McIntosh E, Tang X, Downes CP, et al. Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface. J Biol Chem 2003; 278:39337 - 48; http://dx.doi.org/10.1074/jbc.M305689200; PMID: 12869574
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 2001; 21:5899 - 912; http://dx.doi.org/10.1128/MCB.21.17.5899-5912.2001; PMID: 11486029
   PubMed Web of Science ®Google Scholar
• Edinger AL, Cinalli RM, Thompson CB. Rab7 prevents growth factor-independent survival by inhibiting cell-autonomous nutrient transporter expression. Dev Cell 2003; 5:571 - 82; http://dx.doi.org/10.1016/S1534-5807(03)00291-0; PMID: 14536059
   PubMed Web of Science ®Google Scholar
• Wieman HL, Wofford JA, Rathmell JC. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell 2007; 18:1437 - 46; http://dx.doi.org/10.1091/mbc.E06-07-0593; PMID: 17301289
   PubMed Web of Science ®Google Scholar
• Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J Immunol 2004; 172:4661 - 5; PMID: 15067038
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Farkash EA, Gao W, Thompson CB. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 2001; 167:6869 - 76; PMID: 11739504
   PubMed Web of Science ®Google Scholar
• Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8:705 - 11; http://dx.doi.org/10.1016/S1097-2765(01)00320-3; PMID: 11583631
   PubMed Web of Science ®Google Scholar
• Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727 - 30; http://dx.doi.org/10.1126/science.1059108; PMID: 11326099
   PubMed Web of Science ®Google Scholar
• Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120:237 - 48; http://dx.doi.org/10.1016/j.cell.2004.11.046; PMID: 15680329
   PubMed Web of Science ®Google Scholar
• Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 2007; 204:25 - 31; http://dx.doi.org/10.1084/jem.20061303; PMID: 17190837
   PubMed Web of Science ®Google Scholar
• Gerland LM, Genestier L, Peyrol S, Michallet MC, Hayette S, Urbanowicz I, et al. Autolysosomes accumulate during in vitro CD8+ T-lymphocyte aging and may participate in induced death sensitization of senescent cells. Exp Gerontol 2004; 39:789 - 800; http://dx.doi.org/10.1016/j.exger.2004.01.013; PMID: 15130673
   PubMed Web of Science ®Google Scholar
• Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 2006; 116:2161 - 72; http://dx.doi.org/10.1172/JCI26185; PMID: 16886061
   PubMed Web of Science ®Google Scholar
• Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 2008; 132:631 - 44; http://dx.doi.org/10.1016/j.cell.2008.01.025; PMID: 18295580
   PubMed Web of Science ®Google Scholar
• Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425:836 - 41; http://dx.doi.org/10.1038/nature02041; PMID: 14574412
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425:841 - 6; http://dx.doi.org/10.1038/nature02040; PMID: 14574413
   PubMed Web of Science ®Google Scholar
• Mahmud N, Devine SM, Weller KP, Parmar S, Sturgeon C, Nelson MC, et al. The relative quiescence of hematopoietic stem cells in nonhuman primates. Blood 2001; 97:3061 - 8; http://dx.doi.org/10.1182/blood.V97.10.3061; PMID: 11342431
   PubMed Web of Science ®Google Scholar
• Orford KW, Scadden DT. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet 2008; 9:115 - 28; http://dx.doi.org/10.1038/nrg2269; PMID: 18202695
   PubMed Web of Science ®Google Scholar
• Cheshier SH, Morrison SJ, Liao X, Weissman IL. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A 1999; 96:3120 - 5; http://dx.doi.org/10.1073/pnas.96.6.3120; PMID: 10077647
   PubMed Web of Science ®Google Scholar
• Phillips RL, Reinhart AJ, Van Zant G. Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics. Proc Natl Acad Sci U S A 1992; 89:11607 - 11; http://dx.doi.org/10.1073/pnas.89.23.11607; PMID: 1280831
   PubMed Web of Science ®Google Scholar
• de Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 1997; 89:1543 - 50; PMID: 9057635
   PubMed Web of Science ®Google Scholar
• Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804 - 8; http://dx.doi.org/10.1126/science.287.5459.1804; PMID: 10710306
   PubMed Web of Science ®Google Scholar
• Haneline LS, White H, Yang FC, Chen S, Orschell C, Kapur R, et al. Genetic reduction of class IA PI-3 kinase activity alters fetal hematopoiesis and competitive repopulating ability of hematopoietic stem cells in vivo. Blood 2006; 107:1375 - 82; http://dx.doi.org/10.1182/blood-2005-05-1985; PMID: 16239435
   PubMed Web of Science ®Google Scholar
• Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006; 441:475 - 82; http://dx.doi.org/10.1038/nature04703; PMID: 16598206
   PubMed Web of Science ®Google Scholar
• Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006; 441:518 - 22; http://dx.doi.org/10.1038/nature04747; PMID: 16633340
   PubMed Web of Science ®Google Scholar
• Kharas MG, Okabe R, Ganis JJ, Gozo M, Khandan T, Paktinat M, et al. Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice. Blood 2010; 115:1406 - 15; http://dx.doi.org/10.1182/blood-2009-06-229443; PMID: 20008787
   PubMed Web of Science ®Google Scholar
• Gan B, Sahin E, Jiang S, Sanchez-Aguilera A, Scott KL, Chin L, et al. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci U S A 2008; 105:19384 - 9; http://dx.doi.org/10.1073/pnas.0810584105; PMID: 19052232
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2009; 2:ra75; http://dx.doi.org/10.1126/scisignal.2000559; PMID: 19934433
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y, et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008; 205:2397 - 408; http://dx.doi.org/10.1084/jem.20081297; PMID: 18809716
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10:858 - 64; http://dx.doi.org/10.1038/nm1075; PMID: 15235597
   PubMed Web of Science ®Google Scholar
• Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 2007; 104:5431 - 6; http://dx.doi.org/10.1073/pnas.0701152104; PMID: 17374716
   PubMed Web of Science ®Google Scholar
• Naka K, Hirao A. Maintenance of genomic integrity in hematopoietic stem cells. Int J Hematol 2011; 93:434 - 9; http://dx.doi.org/10.1007/s12185-011-0793-z; PMID: 21384097
   PubMed Web of Science ®Google Scholar
• Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007; 110:3056 - 63; http://dx.doi.org/10.1182/blood-2007-05-087759; PMID: 17595331
   PubMed Web of Science ®Google Scholar
• Nakada D, Saunders TL, Morrison SJ. Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells. Nature 2010; 468:653 - 8; http://dx.doi.org/10.1038/nature09571; PMID: 21124450
   PubMed Web of Science ®Google Scholar
• Gurumurthy S, Xie SZ, Alagesan B, Kim J, Yusuf RZ, Saez B, et al. The Lkb1 metabolic sensor maintains haematopoietic stem cell survival. Nature 2010; 468:659 - 63; http://dx.doi.org/10.1038/nature09572; PMID: 21124451
   PubMed Web of Science ®Google Scholar
• Gan B, Hu J, Jiang S, Liu Y, Sahin E, Zhuang L, et al. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 2010; 468:701 - 4; http://dx.doi.org/10.1038/nature09595; PMID: 21124456
   PubMed Web of Science ®Google Scholar
• Takubo K, Goda N, Yamada W, Iriuchishima H, Ikeda E, Kubota Y, et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 2010; 7:391 - 402; http://dx.doi.org/10.1016/j.stem.2010.06.020; PMID: 20804974
   PubMed Web of Science ®Google Scholar
• Kim M, Cooper DD, Hayes SF, Spangrude GJ. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 1998; 91:4106 - 17; PMID: 9596656
   PubMed Web of Science ®Google Scholar
• Siggins RW, Zhang P, Welsh D, Lecapitaine NJ, Nelson S. Stem cells, phenotypic inversion, and differentiation. Int J Clin Exp Med 2008; 1:2 - 21; PMID: 19079683
   PubMed Web of Science ®Google Scholar
• Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell molecular signature. Science 2002; 298:601 - 4; http://dx.doi.org/10.1126/science.1073823; PMID: 12228721
   PubMed Web of Science ®Google Scholar
• Chen C, Liu Y, Liu Y, Zheng P. The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle 2009; 8:1158 - 60; http://dx.doi.org/10.4161/cc.8.8.8139; PMID: 19270502
   PubMed Web of Science ®Google Scholar
• Schieke SM, Phillips D, McCoy JP Jr., Aponte AM, Shen RF, Balaban RS, et al. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 2006; 281:27643 - 52; http://dx.doi.org/10.1074/jbc.M603536200; PMID: 16847060
   PubMed Web of Science ®Google Scholar
• Ferber EC, Peck B, Delpuech O, Bell GP, East P, Schulze A. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ 2011; In press http://dx.doi.org/10.1038/cdd.2011.179; PMID: 22139133
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H, et al. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 2006; 25:3515 - 23; http://dx.doi.org/10.1038/sj.emboj.7601236; PMID: 16858398
   PubMed Web of Science ®Google Scholar
• Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007; 128:325 - 39; http://dx.doi.org/10.1016/j.cell.2007.01.003; PMID: 17254970
   PubMed Web of Science ®Google Scholar
• Mortensen M, Soilleux EJ, Djordjevic G, Tripp R, Lutteropp M, Sadighi-Akha E, et al. The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J Exp Med 2011; 208:455 - 67; http://dx.doi.org/10.1084/jem.20101145; PMID: 21339326
   PubMed Web of Science ®Google Scholar
• Martin P. Wound healing--aiming for perfect skin regeneration. Science 1997; 276:75 - 81; http://dx.doi.org/10.1126/science.276.5309.75; PMID: 9082989
   PubMed Web of Science ®Google Scholar
• Pollina EA, Legesse-Miller A, Haley EM, Goodpaster T, Randolph-Habecker J, Coller HA. Regulating the angiogenic balance in tissues. Cell Cycle 2008; 7:2056 - 70; http://dx.doi.org/10.4161/cc.7.13.6240; PMID: 18642446
   PubMed Web of Science ®Google Scholar
• Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, et al. The transcriptional program in the response of human fibroblasts to serum. Science 1999; 283:83 - 7; http://dx.doi.org/10.1126/science.283.5398.83; PMID: 9872747
   PubMed Web of Science ®Google Scholar
• Desmoulière A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005; 13:7 - 12; http://dx.doi.org/10.1111/j.1067-1927.2005.130102.x; PMID: 15659031
   PubMed Web of Science ®Google Scholar
• Köse O, Waseem A. Keloids and hypertrophic scars: are they two different sides of the same coin?. Dermatol Surg 2008; 34:336 - 46; http://dx.doi.org/10.1111/j.1524-4725.2007.34067.x; PMID: 18177398
   PubMed Web of Science ®Google Scholar
• Lemons JM, Feng XJ, Bennett BD, Legesse-Miller A, Johnson EL, Raitman I, et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010; 8:e1000514; http://dx.doi.org/10.1371/journal.pbio.1000514; PMID: 21049082
   PubMed Web of Science ®Google Scholar
• Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 1996; 16:4327 - 36; PMID: 8754833
   PubMed Web of Science ®Google Scholar
• Rivard N, L’Allemain G, Bartek J, Pouysségur J. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J Biol Chem 1996; 271:18337 - 41; http://dx.doi.org/10.1074/jbc.271.31.18337; PMID: 8702474
   PubMed Web of Science ®Google Scholar
• Liu H, Adler AS, Segal E, Chang HY. A transcriptional program mediating entry into cellular quiescence. PLoS Genet 2007; 3:e91; http://dx.doi.org/10.1371/journal.pgen.0030091; PMID: 17559306
   PubMedGoogle Scholar
• Kovacevic Z, McGivan JD. Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev 1983; 63:547 - 605; PMID: 6132422
   PubMed Web of Science ®Google Scholar
• Zielke HR, Zielke CL, Ozand PT. Glutamine: a major energy source for cultured mammalian cells. Fed Proc 1984; 43:121 - 5; PMID: 6690331
   PubMedGoogle Scholar
• Reitzer LJ, Wice BM, Kennell D. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 1979; 254:2669 - 76; PMID: 429309
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Blagosklonny MV. Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 2008; 7:3355 - 61; http://dx.doi.org/10.4161/cc.7.21.6919; PMID: 18948731
   PubMed Web of Science ®Google Scholar
• Vousden KH. Outcomes of p53 activation--spoilt for choice. J Cell Sci 2006; 119:5015 - 20; http://dx.doi.org/10.1242/jcs.03293; PMID: 17158908
   PubMed Web of Science ®Google Scholar
• Itahana K, Dimri G, Campisi J. Regulation of cellular senescence by p53. Eur J Biochem 2001; 268:2784 - 91; http://dx.doi.org/10.1046/j.1432-1327.2001.02228.x; PMID: 11358493
   PubMedGoogle Scholar
• Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 2009; 9:862 - 73; http://dx.doi.org/10.1038/nrc2763; PMID: 19935675
   PubMed Web of Science ®Google Scholar
• Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303:844 - 8; http://dx.doi.org/10.1126/science.1092472; PMID: 14704432
   PubMed Web of Science ®Google Scholar
• Vassilev LT. Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics. Cell Cycle 2004; 3:419 - 21; http://dx.doi.org/10.4161/cc.3.4.801; PMID: 15004525
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344 - 52; PMID: 20606252
   PubMedGoogle Scholar
• Korotchkina LG, Demidenko ZN, Gudkov AV, Blagosklonny MV. Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A. Cell Cycle 2009; 8:3777 - 81; http://dx.doi.org/10.4161/cc.8.22.10121; PMID: 19855165
   PubMed Web of Science ®Google Scholar
• Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschläger M. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem 1997; 272:29301 - 8; http://dx.doi.org/10.1074/jbc.272.46.29301; PMID: 9361010
   PubMed Web of Science ®Google Scholar
• Soucek T, Yeung RS, Hengstschläger M. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci U S A 1998; 95:15653 - 8; http://dx.doi.org/10.1073/pnas.95.26.15653; PMID: 9861025
   PubMed Web of Science ®Google Scholar
• Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004; 10:8152 - 62; http://dx.doi.org/10.1158/1078-0432.CCR-04-1110; PMID: 15623589
   PubMed Web of Science ®Google Scholar
• Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992; 340:685 - 9; http://dx.doi.org/10.1016/0140-6736(92)92230-D; PMID: 1381801
   PubMed Web of Science ®Google Scholar
• Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337:1188 - 94; http://dx.doi.org/10.1056/NEJM199710233371702; PMID: 9337377
   PubMed Web of Science ®Google Scholar
• Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007; 7:834 - 46; http://dx.doi.org/10.1038/nrc2256; PMID: 17957189
   PubMed Web of Science ®Google Scholar
• Zippelius A, Pantel K. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci 2000; 906:110 - 23; http://dx.doi.org/10.1111/j.1749-6632.2000.tb06600.x; PMID: 10818606
   PubMed Web of Science ®Google Scholar
• Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13:58 - 68; http://dx.doi.org/10.1016/j.ccr.2007.12.003; PMID: 18167340
   PubMed Web of Science ®Google Scholar
• Cutuli B, Cohen-Solal-Le Nir C, De Lafontan B, Mignotte H, Fichet V, Fay R, et al. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur J Cancer 2001; 37:2365 - 72; http://dx.doi.org/10.1016/S0959-8049(01)00303-3; PMID: 11720829
   PubMed Web of Science ®Google Scholar
• Schardt JA, Meyer M, Hartmann CH, Schubert F, Schmidt-Kittler O, Fuhrmann C, et al. Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. Cancer Cell 2005; 8:227 - 39; http://dx.doi.org/10.1016/j.ccr.2005.08.003; PMID: 16169467
   PubMed Web of Science ®Google Scholar
• Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell 2001; 12:863 - 79; PMID: 11294892
   PubMed Web of Science ®Google Scholar
• Ossowski L, Reich E. Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell 1983; 33:323 - 33; http://dx.doi.org/10.1016/0092-8674(83)90414-2; PMID: 6407756
   PubMed Web of Science ®Google Scholar
• Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res 2004; 64:7336 - 45; http://dx.doi.org/10.1158/0008-5472.CAN-04-0113; PMID: 15492254
   PubMed Web of Science ®Google Scholar
• Schewe DM, Aguirre-Ghiso JA. ATF6alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci U S A 2008; 105:10519 - 24; http://dx.doi.org/10.1073/pnas.0800939105; PMID: 18650380
   PubMed Web of Science ®Google Scholar
• Dey-Guha I, Wolfer A, Yeh AC, G Albeck J, Darp R, Leon E, et al. Asymmetric cancer cell division regulated by AKT. Proc Natl Acad Sci U S A 2011; 108:12845 - 50; http://dx.doi.org/10.1073/pnas.1109632108; PMID: 21757645
   PubMed Web of Science ®Google Scholar
• Sang L, Coller HA, Roberts JM. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008; 321:1095 - 100; http://dx.doi.org/10.1126/science.1155998; PMID: 18719287
   PubMed Web of Science ®Google Scholar
• Pantic I. Cancer stem cell hypotheses: impact on modern molecular physiology and pharmacology research. J Biosci 2011; 36:957 - 61; PMID: 22116294
   PubMed Web of Science ®Google Scholar
• Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L, Menendez JA. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype. Cell Cycle 2011; 10:3871 - 85; http://dx.doi.org/10.4161/cc.10.22.17976; PMID: 22127234
   PubMed Web of Science ®Google Scholar
• Miller TW, Rexer BN, Garrett JT, Arteaga CL. Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Res 2011; 13:224; http://dx.doi.org/10.1186/bcr3039; PMID: 22114931
   PubMed Web of Science ®Google Scholar
• Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, et al. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res 2005; 65:10992 - 1000; http://dx.doi.org/10.1158/0008-5472.CAN-05-2612; PMID: 16322248
   PubMed Web of Science ®Google Scholar
• Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10:51 - 64; http://dx.doi.org/10.1016/j.ccr.2006.06.001; PMID: 16843265
   PubMed Web of Science ®Google Scholar
• Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev 2011; 25:717 - 29; http://dx.doi.org/10.1101/gad.2016111; PMID: 21406549
   PubMed Web of Science ®Google Scholar
• Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25:460 - 70; http://dx.doi.org/10.1101/gad.2016311; PMID: 21317241
   PubMed Web of Science ®Google Scholar
• Maclean KH, Dorsey FC, Cleveland JL, Kastan MB. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 2008; 118:79 - 88; http://dx.doi.org/10.1172/JCI33700; PMID: 18097482
   PubMed Web of Science ®Google Scholar
• Wei H, Wei S, Gan B, Peng X, Zou W, Guan JL. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 2011; 25:1510 - 27; http://dx.doi.org/10.1101/gad.2051011; PMID: 21764854
   PubMed Web of Science ®Google Scholar
• Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011; 8:528 - 39; http://dx.doi.org/10.1038/nrclinonc.2011.71; PMID: 21587219
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011; 17:654 - 66; http://dx.doi.org/10.1158/1078-0432.CCR-10-2634; PMID: 21325294
   PubMed Web of Science ®Google Scholar
• White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15:5308 - 16; http://dx.doi.org/10.1158/1078-0432.CCR-07-5023; PMID: 19706824
   PubMed Web of Science ®Google Scholar
• Cheng Y, Li H, Ren X, Niu T, Hait WN, Yang J. Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition. PLoS One 2010; 5:e9715; http://dx.doi.org/10.1371/journal.pone.0009715; PMID: 20300520
   PubMedGoogle Scholar
• Abarientos C, Sperber K, Shapiro DL, Aronow WS, Chao CP, Ash JY. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy. Expert Opin Drug Saf 2011; 10:705 - 14; http://dx.doi.org/10.1517/14740338.2011.566555; PMID: 21417950
   PubMed Web of Science ®Google Scholar
• Ohsumi Y. Molecular mechanism of autophagy in yeast, Saccharomyces cerevisiae.. Philos Trans R Soc Lond B Biol Sci 1999; 354:1577 - 80, discussion 1580-1; http://dx.doi.org/10.1098/rstb.1999.0501; PMID: 10582243
   PubMed Web of Science ®Google Scholar
• Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans.. Science 1997; 277:942 - 6; http://dx.doi.org/10.1126/science.277.5328.942; PMID: 9252323
   PubMed Web of Science ®Google Scholar
• Wei M, Fabrizio P, Madia F, Hu J, Ge H, Li LM, et al. Tor1/Sch9-regulated carbon source substitution is as effective as calorie restriction in life span extension. PLoS Genet 2009; 5:e1000467; http://dx.doi.org/10.1371/journal.pgen.1000467; PMID: 19424415
   PubMed Web of Science ®Google Scholar
• Jacobs SR, Herman CE, Maciver NJ, Wofford JA, Wieman HL, Hammen JJ, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 2008; 180:4476 - 86; PMID: 18354169
   PubMed Web of Science ®Google Scholar
• Tarazona AM, Rodríguez JI, Restrepo LF, Olivera-Angel M. Mitochondrial activity, distribution and segregation in bovine oocytes and in embryos produced in vitro. Reprod Domest Anim 2006; 41:5 - 11; http://dx.doi.org/10.1111/j.1439-0531.2006.00615.x; PMID: 16420320
   PubMed Web of Science ®Google Scholar
• Bavister BD, Squirrell JM. Mitochondrial distribution and function in oocytes and early embryos. Hum Reprod 2000; 15:Suppl 2 189 - 98; PMID: 11041524
   PubMedGoogle Scholar
• Hengge-Aronis R, Klein W, Lange R, Rimmele M, Boos W. Trehalose synthesis genes are controlled by the putative sigma factor encoded by rpoS and are involved in stationary-phase thermotolerance in Escherichia coli.. J Bacteriol 1991; 173:7918 - 24; PMID: 1744047
   PubMed Web of Science ®Google Scholar
• Elbein AD, Pan YT, Pastuszak I, Carroll D. New insights on trehalose: a multifunctional molecule. Glycobiology 2003; 13:17R - 27R; http://dx.doi.org/10.1093/glycob/cwg047; PMID: 12626396
   PubMed Web of Science ®Google Scholar
• Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002; 16:769 - 77; http://dx.doi.org/10.1016/S1074-7613(02)00323-0; PMID: 12121659
   PubMed Web of Science ®Google Scholar
• Rusten TE, Lindmo K, Juhász G, Sass M, Seglen PO, Brech A, et al. Programmed autophagy in the Drosophila fat body is induced by ecdysone through regulation of the PI3K pathway. Dev Cell 2004; 7:179 - 92; http://dx.doi.org/10.1016/j.devcel.2004.07.005; PMID: 15296715
   PubMed Web of Science ®Google Scholar
• Scott RC, Schuldiner O, Neufeld TP. Role and regulation of starvation-induced autophagy in the Drosophila fat body. Dev Cell 2004; 7:167 - 78; http://dx.doi.org/10.1016/j.devcel.2004.07.009; PMID: 15296714
   PubMed Web of Science ®Google Scholar
• Kurath G, Morita RY. Starvation-survival physiological studies of a marine Pseudomonas sp. Appl Environ Microbiol 1983; 45:1206 - 11; PMID: 16346265
   PubMed Web of Science ®Google Scholar
• Kolter R, Siegele DA, Tormo A. The stationary phase of the bacterial life cycle. Annu Rev Microbiol 1993; 47:855 - 74; http://dx.doi.org/10.1146/annurev.mi.47.100193.004231; PMID: 8257118
   PubMed Web of Science ®Google Scholar
• Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479:232 - 6; http://dx.doi.org/10.1038/nature10600; PMID: 22048312
   PubMed Web of Science ®Google Scholar